Skip to main content

Jim Cramer Is More Focused on Vaccine Rollout Than Vaccine Stocks

Publish date:
Video Rating:
Video Duration:

Moderna  (MRNA) - Get Moderna, Inc. Report released data on its vaccine candidate. 

Moderna's 94.5% efficacy rate topped the 90% threshold reported by Pfizer last week and noted the vaccine can last for up to six months when stored at standard freezer temperatures. 

Jim Cramer weighs in on Moderna's vaccine candidate and the bullishness of investors in this market. 

WATCH: Everything Jim Cramer Is Watching in the Markets Monday

Latest Videos From TheStreet and Jim Cramer:

Related Videos